Which of the following is a genetic disorder in which the blood takes too long to clot? a. ...

Author Question: Which of the following is a genetic disorder in which the blood takes too long to clot? a. ... (Read 91 times)

luvbio

Hero Member
Posts: 623

on: Jun 27, 2018

Which of the following is a genetic disorder in which the blood takes too long to clot?

a. Polycythemia
b. Sickle cell anemia
c. Pernicious anemia
d. Hemophilia

Question 2

Which of the following is NOT a way physicians diagnose blood disorders?

a. Bone marrow biopsy
b. Blood tests
c. Blood biopsy
d. Microscopic examination of blood cells

chjcharjto14

Sr. Member
Posts: 342

Reply #1 on: Jun 27, 2018

Answer to Question 1

Answer: d

Answer to Question 2

Answer: c

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.